Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection
Clinical trial NCT06706310 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06706310
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2025-06-22
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.